Conatus Pharmaceuticals (CNAT) – Analyst PT Change
-
UPDATE: Roth Capital Downgrades Conatus Pharmaceuticals (CNAT) to Neutral
-
H.C. Wainwright Downgrades Conatus Pharmaceuticals (CNAT) to Neutral
-
-
-
-
-
-
-
-
-
-
Back to CNAT Stock Lookup